Global Malaria Diagnostics Market Report and Forecast 2024-2032

Malaria Diagnostics Market: Introduction and Overview

Malaria refers to an intermittent and remittent fever caused by a protozoan parasite carried by female Anopheles mosquitoes that invades the red blood cells in the tropical and sub-tropical regions. Patients suffering from malaria often experience fever, chills, and flu-like symptoms. In patients infected by malaria, malaria causing parasite grows and multiplies first in the liver cells and then in the red blood cell. Malaria is usually curable, but it can become fatal if not taken care of properly. Malaria diagnostics refers to the process of identification of the parasite through blood smears under a microscope or through a rapid diagnostic test (RDT).

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Based on technology, the molecular diagnostic test segment is predicted to account for a substantial market share in the malaria diagnostics market. This increase can be associated with the high accuracy of these tests in detecting different variants of malaria-causing parasites. These tests are conducted in two ways, namely the polymerase chain reaction (PCR) and quantitative or real time-PCR (qPCR). These tests help detect low parasite counts and mixed infection cases. Moreover, these tests are incredibly sensitive and highly accurate even while detecting low levels of infections. Thus, this segment is estimated to positively catalyse the market growth over the forecast period.

Based on regions, Middle East and Africa is expected to occupy a substantial share of the malaria diagnostics market during the forecast period. This growth can be attributed to the growing prevalence of malaria in the region caused by the widespread malaria vector, Anopheles gambiae, which is difficult to control. According to the WHO statistics of 2019, the African region alone was home to 94% of all malaria cases and deaths worldwide.

Moreover, with the growing geriatric population who are more susceptible to such infections, governments are increasingly investing in the healthcare sector to reduce mortality risks associated with malaria. As a result, malaria diagnostics technology is witnessing a significant demand for the early detection of the disease. These factors are expected to contribute to the industry growth significantly.

Malaria Diagnostics Market Segmentations

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Malaria Diagnostics Market Scenario

According to the WHO statistics of 2019, an estimated 299 million malaria cases were reported in the year, while the total number of deaths caused by malaria stood at 409 thousand in 2019. Out of these, children below five years of age accounted for 67% of all malaria-related deaths worldwide. This is due to the compromised immune system of children due to malnourishment and undernutrition.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

In addition, children with severe malaria infection also show severe anaemia, respiratory issues concerning metabolic acidosis, or cerebral malaria. In the malaria endemic regions, the transmission speed of malaria increases with the longer life span of mosquitoes with a human-biting tendency. For instance, in Africa, the African vector mosquito species have a longer life span and are responsible for the 90% of the world's malaria cases. In this regard, countries worldwide and international organisations are introducing initiatives to control the spread and prevent malaria risks.

For instance, the WHO’s Global Malaria Programme and Malaria Consortium's Malaria Prevention and Control Project aim to prevent, protect, and treat children in collaboration with several countries such as Burkina Faso, Cameroon, the Democratic Republic of the Congo, Ghana, Mozambique. Such developments are expected to augment the market growth in the forecast period.

Competitive Landscape of the Global Malaria Diagnostics Market

The report gives a detailed analysis of the key players in the global malaria diagnostics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

• ACCESS BIO. INC

• Abbott

• BioMérieux SA

• Ortho Clinical Diagnostics

• Thermo Fisher Scientific

• PREMIER MEDICAL CORPORATION PVT LTD.

• Siemens, Bio-Rad Laboratories, Inc.

• Hemex Health

• QuantuMDx Group Ltd.

• Meridian Bioscience Europe B.V.

• Intellectual Ventures Management LLC.

• Novartis AG

• BD

• FYODOR BIOTECHNOLOGIES

• Drucker Diagnostics

• Danaher

• Beckman Coulter, Inc.

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model and SWOT analysis.